Lombard Medical Stock Performance
| EVARF Stock | USD 0.0001 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Lombard Medical are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Lombard Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Lombard Medical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Total Cashflows From Investing Activities | -94 K |
Lombard |
Lombard Medical Relative Risk vs. Return Landscape
If you would invest 0.01 in Lombard Medical on August 14, 2025 and sell it today you would earn a total of 0.00 from holding Lombard Medical or generate 0.0% return on investment over 90 days. Lombard Medical is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Lombard, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Lombard Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lombard Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Lombard Medical, and traders can use it to determine the average amount a Lombard Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| EVARF |
Based on monthly moving average Lombard Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lombard Medical by adding Lombard Medical to a well-diversified portfolio.
Lombard Medical Fundamentals Growth
Lombard Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Lombard Medical, and Lombard Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lombard Pink Sheet performance.
| Return On Equity | -1.09 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (2.55) % | |||
| Operating Margin | (2.10) % | |||
| Current Valuation | 11.76 M | |||
| Shares Outstanding | 27.95 M | |||
| Price To Sales | 0.02 X | |||
| Revenue | 12.17 M | |||
| EBITDA | (24.22 M) | |||
| Cash And Equivalents | 20.8 M | |||
| Cash Per Share | 0.74 X | |||
| Total Debt | 30.29 M | |||
| Debt To Equity | 2.47 % | |||
| Book Value Per Share | 0.50 X | |||
| Cash Flow From Operations | (25.2 M) | |||
| Earnings Per Share | (1.54) X | |||
| Total Asset | 67.77 M | |||
About Lombard Medical Performance
By analyzing Lombard Medical's fundamental ratios, stakeholders can gain valuable insights into Lombard Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Lombard Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Lombard Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom. LOMBARD MED operates under Medical Devices classification in the United States and is traded on PNK Exchange. It employs 113 people.Things to note about Lombard Medical performance evaluation
Checking the ongoing alerts about Lombard Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Lombard Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lombard Medical generated a negative expected return over the last 90 days | |
| Lombard Medical has some characteristics of a very speculative penny stock | |
| Lombard Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 12.17 M. Net Loss for the year was (31.04 M) with profit before overhead, payroll, taxes, and interest of 1.14 M. | |
| Lombard Medical has accumulated about 20.8 M in cash with (25.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Lombard Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lombard Medical's stock is overvalued or undervalued compared to its peers.
- Examining Lombard Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lombard Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lombard Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lombard Medical's pink sheet. These opinions can provide insight into Lombard Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Lombard Pink Sheet analysis
When running Lombard Medical's price analysis, check to measure Lombard Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lombard Medical is operating at the current time. Most of Lombard Medical's value examination focuses on studying past and present price action to predict the probability of Lombard Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lombard Medical's price. Additionally, you may evaluate how the addition of Lombard Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |